Altretamine

CHEMBL1455 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
210.3 g/mol
LogP
2.7
Phase
4

An oral alkylating-like antineoplastic agent used to treat ovarian cancer that has persisted or recurred after standard platinum-based chemotherapy, though its precise mechanism is not fully understood. It disrupts cancer cell metabolism and DNA function, providing an option for patients whose disease has become resistant to other treatments.

Peso Molecular

210,2800 g/mol

LogP

2,70

TPSA

48,40 Ų

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)c1nc(N(C)C)nc(N(C)C)n1

InChI

InChI=1S/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H3

Molecular Formula

C9H18N6

HBD / HBA

- / 6

Ligações Rotacionáveis

3

Átomos Pesados

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

An oral alkylating-like antineoplastic agent used to treat ovarian cancer that has persisted or recurred after standard platinum-based chemotherapy, though its precise mechanism is not fully understood. It disrupts cancer cell metabolism and DNA function, providing an option for patients whose disease has become resistant to other treatments.

Yes, Altretamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1455. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2123. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.